Multiple antibiotic courses linked to pediatric treatment failure
Data showed that those who had been given at least two previous courses were 32% more likely to fail to respond to a subsequent course.
Read More
Tag: pediatric
FDA approves Ruzurgi for children with Lambert-Eaton myasthenic syndrome
The FDA has also granted the application Priority Review and Fast Track designations.
Read More
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
